JUL 21, 2016 7:00 AM PDT

Trace Element Blocks Cancer's Defenses Against Chemo Drugs

WRITTEN BY: Xuan Pham
Chemotherapy is highly effective against cancer when the cancer hasn’t found ways to subvert the treatment. The challenge is that cancer is cunning and can mutate to become resistant to the drugs, resulting in many patient deaths. Now, by combing through molecules that can bypass cancer’s defenses, researchers have stumbled on new compounds that can actually kill multidrug-resistant mouse cancer cells.

Selenium-based compounds block efflux pumps, boost chemo treatments | Image: l120y.com

The compounds are organic and inorganic derivatives of a chemical element known as selenium (atomic number 34). This trace element is essential for normal biological processes, such as reproduction, metabolism, DNA synthesis, and protection from infection. Selenium deficiency can lead to diseases, such as cardiomyopathies (Keshan disease) and bone disorders (Kashin-Beck disease). Furthermore, previous research suggested selenocompounds may have potent anticancer effects.

Indeed, the present study demonstrated selenocompounds prevent cancer cells from becoming resistant to chemotherapeutic drugs, thereby boosting the efficacy of the actual chemotherapy.
In particular, the researchers honed in on how selenocompounds affect the efflux pumps on cells. Normally, the efflux pumps are located on the cell membrane and act to push toxins out of the cells as a protective mechanism. In cancer, the efflux pumps are coerced into pumping out the chemotherapy drugs, which prevent the cancer cells from being killed. Selenocompounds essentially block the efflux pumps from working in cancer cells, thus making the cells susceptible to drugs that were once considered ineffective.
 

"Our research reports a new way to fight multi-drug resistance in cancer,” said Enrique Domínguez-Álvarez, professor at the University of Navarra in Pamplona, and first author of the study. Still, he tempered the team’s results with caution: “We are realistic and we know that much more research needs to be done, but we are excited about these promising results that open new and unexplored possibilities."

So far, the successes of selenocompounds have only been demonstrated on mouse T-lymphoma cells that are resistant to multiple drugs. But the battery of experiments revealed that blocking the efflux pumps led to more cancer cell death; some compounds were reported to kill as much as 80 percent of the mouse cancer cells. These are extremely good news for patients who have the exhausted the list of available drugs to treat their highly resistant cancer.

“The ultimate aim of cancer research is to give more chances to people whose lives are at risk due to this disease. The development of pharmaceutical drugs requires a lot of effort and time, and the results our group presents are just preliminary. But contributing my effort to this fight, even in these starting steps, fulfills me. I hope that in the future our work will serve as the basis to develop new drugs against cancer that reach the patients who need them,” said Domínguez-Álvarez.

Additional source: NIH, Elsevier press release
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
AUG 12, 2021
Cancer
Promising Drug Target Identified for Deadly Ovarian Cancer
AUG 12, 2021
Promising Drug Target Identified for Deadly Ovarian Cancer
Scientists at the University of Alabama at Birmingham have identified a gene called DOT1L for its role in progressing th ...
AUG 25, 2021
Chemistry & Physics
Self-Assembling Molecules: A Potential "One-Size-Fits-All" Cancer Therapy
AUG 25, 2021
Self-Assembling Molecules: A Potential "One-Size-Fits-All" Cancer Therapy
A new study from the University of Huddersfield shows promising breakthroughs on the use of self-assembling molecules as ...
SEP 02, 2021
Cancer
When Cholesterol Doesn't Kill Cancer, it Makes it Stronger!
SEP 02, 2021
When Cholesterol Doesn't Kill Cancer, it Makes it Stronger!
High cholesterol is associated with an increased risk of several types of cancer, and cancer patients with high choleste ...
SEP 30, 2021
Cancer
Gut Microbiota Influences Colon Cancer Development
SEP 30, 2021
Gut Microbiota Influences Colon Cancer Development
The gut microbiome consists of all the microorganisms living in an individual’s digestive system. Various factors ...
OCT 07, 2021
Cell & Molecular Biology
Color-Changing Slides Improve Accuracy in Cancer Diagnosis
OCT 07, 2021
Color-Changing Slides Improve Accuracy in Cancer Diagnosis
When cancer is diagnosed, a sample has to be taken from a patient, treated, and analyzed. Researchers have now modified ...
NOV 09, 2021
Immunology
Wikipedia, but Make It Immune Cells
NOV 09, 2021
Wikipedia, but Make It Immune Cells
Scientists have established the first searchable database of complex immune data, providing the foundations for a new er ...
Loading Comments...